Brovana (arformoterol tartrate)
COPD
ApprovedCommercial
Key Facts
About Bausch Health
Bausch Health Companies Inc. is a multinational company dedicated to improving people's lives through its portfolio of pharmaceutical, medical device, and over-the-counter products. Its strategy revolves around its core therapeutic areas, leveraging a mix of in-house R&D and strategic acquisitions, most notably the Bausch + Lomb eye health business. The company is executing a turnaround plan focused on debt reduction, portfolio optimization, and growth in key segments like gastroenterology and aesthetics to drive long-term shareholder value.
View full company profileTherapeutic Areas
Other COPD Drugs
| Drug | Company | Phase |
|---|---|---|
| Breztri | AstraZeneca | Approved |
| Dupixent | Regeneron Pharmaceuticals | Phase 3 |
| Generic Spiriva (Tiotropium) | Lupin Limited | Approved |
| GB-0895 | Generate Biomedicines | Phase 1 |
| Tiotropium/Olodaterol (Spiolto) | KYORIN Pharmaceutical | Approved |
| Yupelri® (revefenacin) | Cleo Life Sciences | Approved |